Teva Pharmaceutical Industries earnings

Next report

Expected around late October, going by its own filing history. The company has not announced a date yet. Its matching report came Nov 5, 2025 and Nov 6, 2024, before the open.

Who else reports that week: the earnings calendar.

Last report: Jul 29, 2026, 07:00 ET (before the open). The filing on SEC EDGAR ↗

Across the last 4 reports we hold closes for, the first close moved a median 10.75% either way. Up 4 of 4.

Moves are only shown for reports where we hold closing prices.

1. Jul 29, 202607:00 ET · before the open8-K ↗+9.60%1D
2. Apr 29, 202607:00 ET · before the open8-K ↗+11.89%1D
3. Jan 28, 202607:20 ET · before the open8-K ↗+2.09%1D
4. Nov 5, 202507:00 ET · before the open8-K ↗+20.23%1D
5. Jul 30, 202507:06 ET · before the open8-K ↗no price data1D
6. May 7, 202507:00 ET · before the open8-K ↗no price data1D
7. Jan 29, 202507:00 ET · before the open8-K ↗no price data1D
8. Nov 6, 202407:00 ET · before the open8-K ↗no price data1D
9. Jul 31, 202407:00 ET · before the open8-K ↗no price data1D
10. May 8, 202407:01 ET · before the open8-K ↗no price data1D
11. Jan 31, 202407:00 ET · before the open8-K ↗no price data1D
12. Nov 8, 202307:01 ET · before the open8-K ↗no price data1D
13. Aug 2, 202307:00 ET · before the open8-K ↗no price data1D
14. May 10, 202307:01 ET · before the open8-K ↗no price data1D
15. Feb 8, 202307:01 ET · before the open8-K ↗no price data1D

Move = the first close after the release against the close before it. A release after 4pm ET is priced by the next session; one before 9:30am ET by that day’s. Times are when the SEC accepted the 8-K (Item 2.02), which follows the press release by minutes. Closes held from Sep 2, 2025; “no price data” means we don't hold the closes for that report. 1 other Item 2.02 filing, filed weeks ahead of a report (a delivery or preliminary update), is not counted as a report. Prior-session closes only; not a forecast, not advice.